Health Risk Assessment (VI)New1201 2010

Embed Size (px)

Citation preview

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    1/93

    Health Risk Assessment (VI):

    Exposure Assessment (I)

    Kuen-Yuh Wu

    Date: Nov 05, 2009

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    2/93

    Main Contents

    General concept and definition

    Concept of exposure, intake, uptake, and dose

    Approaches to quantitation of exposurePlanning an exposure assessment

    Gathering and developing data for exposure

    assessment

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    3/93

    Definition

    Exposure is defined as contact with chemical

    or agent

    What does contact mean(i) The visible exterior of the person

    (ii) The so-called exchange boundaries where

    absorption takes place EPAs definition is exposure as taking place at

    the visible exterior boundaries

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    4/93

    Definition

    Exposure is defined as the contact a chemical with the

    outer boundary

    Exposure assessment is defined as the qualitative or

    quantitative evaluation of that contact; it describes the

    intensity, frequency, and duration of contact, and

    often evaluates the rate at which the cit crosses the

    chemical crosses the boundary, the route by which it

    crosses the boundary, and the resulting amount of the

    chemical that actually crosses the boundary and the

    amount absorbed

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    5/93

    Definition

    Absorption: either upon crossing the boundary or

    subsequently, leads to the availability of an amount of

    the chemical to biologically significant sites within

    the body

    Intake: physically moving the chemical in question

    through an opening in the outer boundary, typically

    via inhalation, eating, or drinking

    Intake rate: the amount of chemical crossing the outer

    boundary per unit time.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    6/93

    Definition

    Uptake: absorption of the chemical through skin orother tissue such as eye

    Uptake rate: the amount of chemical absorbed perunit time

    The mass transfer for intake is through bulky flow foruptake through diffusion so that uptake can dependon the concentration gradient across the boundary,permeability of the barrier and other factors

    The difference between intake and uptake is theformer has medium enter into the body, the later doesnot

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    7/93

    Exposure

    !2

    1

    )(t

    tdttCE

    E is the magnitude of exposure, C(t) is the exposure

    concentration as a function of time, Ht =t2-t1 is the

    exposure duration. C(t,s) The exposure concentration canbe expanded to a function of time and space, s is the

    location an individual stands, and also can represented as

    (x,y.z)

    !

    2

    1

    2

    1 ),(

    t

    t

    s

    s dtdsstCE

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    8/93

    Definition of dose

    Applied dose: the amount of a chemical at theabsorption barrier available for absorption, is difficultto measure, and is approximately equal to potentialdose

    Potential dose: the potential amount of the chemicalthat could be absorbed if it were 100% bioavailable,or the amount of the chemical ingested, inhaled, or inmaterial applied to the skin. The potential dose for

    ingestion and inhalation is analogous to theadministered dose in a dose-response experiment.The potential dose can be applied for dose-response relationships based on administered dose

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    9/93

    Potential dose (continued)

    For the dermal route, potential dose is the

    amount of chemical applied or the amount of

    chemical in medium applied

    The applied dose, or the amount that reaches

    the exchange boundaries of the skin, lung, or

    gastrointestinal tract, may often less than the

    potential dose if the material is only partly

    bioavailable

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    10/93

    Internal dose

    Internal dose: the amount of a chemical that has beenabsorbed and is available for interaction withbiologically significant receptors

    Delivered dose: the amount transported to anindividual organ, tissue, or fluid of interest

    The biologically effective dose: the amount thatactually reach cells, sites, or membranes where

    adverse effects occur Dose rate: the amount of a chemical dose per unit

    time, or as dose rates on a per-unit-body-weight basis

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    11/93

    Exposure and dose relationships

    Exposure concentrations are very useful inregulations

    Concentration is function of time, while amount and

    time characterize dose. Severity of effect is dependenton the pattern by which the exposure occurs ratherthan the total exposure

    Integrated exposures are useful when a total exposure

    for a particular route is needed Time-weighed average are widely used in risk

    assessment

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    12/93

    Figure illustration of doses

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    13/93

    Figure illustration of doses

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    14/93

    Figure illustration of doses

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    15/93

    Calculation of potential dose

    Simply the integration of the chemical intake rate times theintake rate of the medium over time

    where Dpot is the potential dose and IR(t) is the ingestionrate or inhalation rate

    if C and IRare nearly constant

    ED is the sum of the exposure duration

    BWdttIRtDt

    tpot /)()(

    2

    1

    BWxEDIRxCD

    BWxEDxIRCD

    pot

    i

    iiipot

    /

    /

    !

    !

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    16/93

    Calculation of doses

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    17/93

    Calculation of internal doses

    BWxESAxxKC

    BWdttxSAxKtC

    p

    t

    tp

    /

    /)()(

    int

    int

    2

    1

    !

    !

    BWxAT

    xEDSAxxC

    ADDp

    !int

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    18/93

    Relationships between applied

    dose and internal dosexESAxxFCxMC adhmediumpot !!

    !2

    1

    )(intt

    tapp dttfDD

    xAFDD app!int

    BWxAT

    xEDSAxxC

    BWxAT

    xAxCADD adh

    ediu !!int

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    19/93

    Calculation of internal dose via

    respiratory and oral routes

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    20/93

    Explanation of exposure and dose term

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    21/93

    Main Contents

    General concept and definition

    Concept of exposure, intake, uptake, and dose

    Approaches to quantitation of exposurePlanning an exposure assessment

    Gathering and developing data for exposure

    assessment

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    22/93

    Approaches to quantitation of exposure

    The exposure can be measured at point ofcontact while it is taking place

    Exposure can be estimated by separatelyevaluating the exposure concentration and thetime of contact (scenario evaluation)

    The exposure can be estimated from dose,

    which in turn can be reconstructed throughinternal indicators after exposure has takenplace (reconstruction)

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    23/93

    Another approaches for

    quantitation of exposures Direct measures: sampling on or within a

    person, for example use of personal samplers

    or biomarkers

    Indirect measures: use of models,

    microenvironmental measurements,

    questionnaires

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    24/93

    Measurement of exposure at the

    point-of-contact Measurement of the chemical concentrations at

    the interface between the person and the

    environment as a function of time

    Personal sampling, dermal patch, duplication

    of meal studies

    Direct and accurate measurement

    Expensive, only available for some chemicals,

    and lack of study the relationship between

    long-term and short-term sampling

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    25/93

    Estimates of exposure from

    scenario evaluation Characterization of chemical concentrations todevelop estimates of exposure concentration,

    typically accomplished indirectly by measuring,

    modeling, or using existing data on concentrations inthe bulk media, rather than at the point of contact

    Characterization of time of contact is to identify who

    is exposed and to develop estimates of the frequency

    and duration of exposure, usually done by use of

    demographic data, survey statistics, behavior

    observation, activity diaries, activity model, or

    information, assumption about behavior

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    26/93

    Estimates of exposure from

    scenario evaluation Sometimes, the limiting assumptions or

    boundary conditions may not always be true

    Two methods to approach this problem(i) To evaluate the exposure or dose equation

    under the conditions where the limiting

    assumptions do hold true

    (ii) To deal with the uncertainty caused by the

    divergence from the boundary conditions

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    27/93

    Strength and weakness of

    scenario evaluation Least expensive

    Particularly suited to analysis of risk

    consequence of proposed actions Performed with little or no data

    Best used when some knowledge exists about

    the soundness, validity, and uncertainty underunderlying assumptions

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    28/93

    Reconstruction of internal dose

    Exposure has taken place

    Intake and uptake is available

    Average past exposure rate can be estimated Reconstruction relies on measuring internal

    body indicators

    Biological tissue or fluid measurement mayindicate directly that an exposure has occurred

    The time of sampling for biomarkers can be

    critical

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    29/93

    Reconstruction of internal dose

    The strength is that it demonstrates that exposure to

    and absorption of the chemical has actually taken

    place and theoretically can give a good indication of

    past exposure The drawback is that it will not work for every

    chemical due to the interference or reactive nature of

    the chemical, has not methodologically established

    for every chemicals, data related internal dose to

    exposure are needed and it may be expensive

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    30/93

    Susceptible subgroup or subpopulation

    Higher susceptibility may be the result of a clear difference in

    the way the chemical is processed by the body, or it may be

    the result of being in the extreme part of the normal range in

    metabolism for a population.

    If groups of individuals who have clearly different

    susceptibility characteristics can be identified, they can betreated as a separate subpopulation, and the risk assessment

    for this subgroup may require a different dose-response

    relationship from the one used for the general population.

    When highly susceptible individuals can be identified, butwhen a different dose-response relationship is not appropriate

    or feasible to develop, the risks for these individuals are

    usually treated as part of the variability of the general

    population.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    31/93

    Highly exposed individuals

    Highly exposed individuals, maximum exposedindividual, worst case exposure, and reasonable worstcase exposure have sometimes been applied to avariety ofadhocestimates with unclear target ranges

    The maximum exposed individual has often been

    used synonymously with worst case exposure, toestimate the exposure of the individual with thehighest actual or possible exposure

    An accurate estimate of the exposure of the person inthe distribution with the highest exposure is

    extremely difficult to develop; uncertainty in theestimate usually increases greatly as the moreextreme ends of the distribution are approached.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    32/93

    Highly exposed individuals

    The primary objective when developing an estimateof high-end exposure or dose is to arrive at anestimate that will fall withinthe actual distribution,rather than aboveit

    Conceptually, the high end of the distribution meansabove the 90th percentile of the populationdistribution, but not higher than the individual in thepopulation who has the highest exposure

    The concept of the high-end exposure, as used in this

    guidance, is fundamentally different from terms suchas worst case, in that the estimate is by definitionintended to fall on the actual (or in the case ofscenarios dealing with future exposures, probable)exposure distribution

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    33/93

    Worst case exposure It has historically meant the maximum possible

    exposure, or where everything that can plausiblyhappen to maximize exposure, happens.

    While in actuality, this worst case exposure may fallon the uppermost point of the population distribution,in most cases, it will be somewhat higher than the

    individual in the population with the highestexposure.

    The worst case represents a hypothetical individualand an extreme set of conditions; this will usually notbe observed in an actual population.

    The worst case and the so-called maximum exposedindividual are therefore not synonymous, the formerdescribing a statistical possibility that may or may notoccur in the population, and the latter ostensiblydescribing an individual that does, or is thought to,exist in the population.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    34/93

    High-end exposure

    Conceptually above the 90

    th percentile but belowabout the 98th percentile, reasonable worst caseexposure.

    Above about the 98th percentile has been termed themaximum exposure range.

    Individual risk descriptors will generally require theassessor to make estimates of high-end exposure ordose, and sometimes additional estimates (e.g.,estimates of central tendency such as average or

    median exposure or dose)

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    35/93

    Utility of the hypothesized scenarios

    Exposure scenarios employing these types ofpostulated questions are encountered often in riskassessments, especially in those where actualexposure data are incomplete or nonexistent.

    Although the estimates of individual exposurederived from these assumptions provide numericalvalues for calculating risk, they do so more as amatter of context than a determination of actualexposure.

    They are not the same types of estimates as high-endexposure or risk, where some statement must be madeabout the likelihood of their falling within a specifiedrange in the actual exposure or risk distribution.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    36/93

    Main Contents

    General concept and definition

    Concept of exposure, intake, uptake, and dose

    Approaches to quantitation of exposurePlanning an exposure assessment

    Gathering and developing data for exposure

    assessment

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    37/93

    Purpose

    Why is the study being conducted?

    What questions will the study address? How will the results be used?

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    38/93

    Scope

    Where does the study area begin and end?

    Will inferences be made on a national,

    regional, or local scale? Who or what is to be monitored?

    What chemicals and what media will be

    measured, and for which individuals,populations, or population segments will

    estimates of exposure and dose be developed?

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    39/93

    Level of details

    How accurate must the exposure or dose estimate beto achieve the purpose?

    How detailed must the assessment be to properly

    account for the biological link between exposure,dose, effect, and risk, if necessary?

    How is the depth of the assessment limited byresources (time and money)?

    What is the most effective use of those resources interms of level of detail of the various parts of theassessment?

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    40/93

    Purpose of the exposure assessment

    The particular purpose for which an exposureassessment will be used will often have significant

    implications for the scope, level of detail, and

    approach of the assessment

    Because of the complex nature of exposureassessments, a multidisciplinary approach that

    encompasses the expertise of a variety of scientists is

    necessary.

    Exposure assessors should seek assistance from other

    scientists when they lack the expertise necessary in

    certain areas of the assessment

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    41/93

    Example 1

    If the exposure assessment is to support regulationsfor specific chemical sources, such as point emissionsources, consumer products, or pesticides, then thelink between the source and the exposed orpotentially exposed population is important.

    It is often necessary to trace chemicals from thesource to the point of exposure by using source andfate models and exposure scenarios.

    By examining the individual components of ascenario, assessors can focus their efforts on the

    factors that contribute the most to exposure, andperhaps use the exposure assessment to selectpossible actions to reduce risk.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    42/93

    Example 2 Exposure assessments are often used to compare and

    select control or cleanup options. Most often the scenario evaluation is employed to

    estimate the residual risk associated with each of thealternatives under consideration.

    These estimates are compared to the baseline risk todetermine the relative risk reduction of eachalternative.

    These types of assessments can also be employed tomake screening decisions about whether to further

    investigate a particular chemical. These assessments can also benefit from verification

    through the use of personal or biological monitoringtechniques

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    43/93

    Multi-MediaModel

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    44/93

    Framework of the Multi-Media Model

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    45/93

    Example 3

    Exposure assessment is to set standards forenvironmental media, usually the concentration levelsin the medium that pose a particular risk level areimportant

    These assessments place more emphasis on linking

    concentration levels in the medium with exposure anddose levels of those exposed.

    A combination of media measurements and personalexposure monitoring could be very helpful inassessments for this purpose

    Modeling may also support or supplement theseassessments.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    46/93

    Example 4 Exposure assessment is to determine the need to remediate a

    waste site or chemical spill, the emphasis is on calculating therisk to an individual or small group, comparing that risk to anacceptable risk level, and if necessary determining appropriatecleanup actions to reach an acceptable risk.

    Although personal exposure monitoring can give a goodindication of the exposure or dose at the present time, often the

    risk manager must make a decision that will protect health inthe future.

    For this reason, modeling and scenario development are theprimary techniques used in this type of assessment.

    Emphasis is usually placed on linking sources with the

    exposed individuals. Biological monitoring may also be helpful (in cases where the

    methodology is established) in determining if exposureactually results in a dose, since some chemicals are not

    bioavailable even if intake occurs.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    47/93

    Example 5

    Exposure assessment is used as a screening device for settingpriorities, the emphasis is more on the comparative risk levels,perhaps with the risk estimates falling into broad categories(e.g., semi-quantitative categories such as high, medium, andlow).

    For such quick-sorting exercises, rarely are any techniquesused other than modeling and scenario development.

    Decisions made in such cases rarely involve direct cleanup orregulatory action without further refinement of the riskassessment, so the scenario development approach can be a

    cost-effective way to set general priorities for futureinvestigation of worst risk first.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    48/93

    Example 6

    If the exposure assessment is wholly predictive

    in nature, a modeling and scenario

    development approach is recommended.

    In such cases, measurement of chemicals yet

    to be manufactured or in the environment is

    not possible.

    In this case again, the link between source and

    exposed individuals is emphasized.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    49/93

    Exposure assessments for status and trends

    Exposure assessments can be used to determine whetherexposure occurs and to monitor status and trends.

    The emphasis is on what the actual exposure (or dose) is at oneparticular time, and how the exposure changes over time.

    Exposure status is the snapshot of exposure at a given time,usually the exposure profile of a population or populationsegment

    Exposure trends show how this profile changes with time.

    Normally, status and trends studies make use of statisticalsampling strategies to assure that changes can be interpretedmeaningfully.

    These data are particularly useful if actions for riskamelioration and demonstration of the effectiveness of theseactions can be made through exposure trend measurements

    E t i

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    50/93

    Exposure assessments in

    epidemiologic studies

    The emphasis is on using the exposure assessment to establishexposure-incidence (or dose-effect) relationships.

    For this purpose, personal monitoring, biological monitoring,and scenario development have all been used

    If the population under study is being currently exposed,

    personal monitoring or biological monitoring may beparticularly helpful

    If the exposure took place in the past, biological monitoringmay provide useful data,

    Scenario development techniques are used to estimate

    exposure in the past, and often the accuracy of the estimate islimited to classifying exposure as high, medium, or low, butsometimes it is very difficult to determine who belongs in acategory, and to interpret the results of the study

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    51/93

    Scope of the assessment The scope of an assessment refers to its comprehensiveness

    The purpose of the exposure assessment will usually helpdefine the scope. There are characteristics that are unique tonational exposure assessments as opposed to industry-wide orlocal exposure assessments

    Exposure assessments in support of national regulations mustbe national in scope; exposure assessments to support cleanupdecisions at a site will be local in scope.

    Exposure assessments to support standards for a particularmedium will often concentrate on that mediums concentrationlevels and typical exposure pathways and routes, although theother pathways and routes are also often estimated for

    perspective.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    52/93

    Level of details of the assessment The level of detail, or depth of the assessment, is

    measured by the amount and resolution of the dataused, and the sophistication of the analysis employed.

    It is determined by the purpose of the exposureassessment and the resources available to perform the

    assessment. To conserve resources, most assessments are done in

    an iterative fashion, with a screening done first;successive iterations add more detail and

    sophistication Resource-limited assessments should be evaluated in

    terms of what part of the original objectives havebeen accomplished, and how this affects the use of

    the results.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    53/93

    Level of details and uncertainty

    The level of detail of an exposure assessment can also

    be influenced by the level of sophistication or

    uncertainty in the assessment of health effects to be

    used for a risk assessment. If only very weak health information is available, a

    detailed, costly, and in-depth exposure assessment

    will in most cases be wasteful, since the most detailed

    information will not add significantly to the certaintyof the risk assessment.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    54/93

    Determining the approach for the

    exposure assessment

    Each approach has its own unique characteristics, strengths,and weaknesses, but the estimate should theoretically be thesame, independent of the approach taken

    The point-of-contact approach: better estimate of exposure or

    dose, but costly and may present logistical challenges(personal continuous-sampling devices), and require publiccooperation.

    The scenario evaluation approach: inexpensive and time-saving, but model uncertainty and validation and exposure

    factors The reconstruction of dose approach: most expensive, not

    every chemical available

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    55/93

    Selecting the approach

    It should include developing an estimate having an acceptableamount of uncertainty.

    In general, estimates based on quality-assured measurementdata, gathered to directly answer the questions of theassessment, are likely to have less uncertainty than estimates

    based on indirect information. The approach selected for the assessment will determine whichdata are needed.

    All three approaches also require data on intake and uptakerates if the final product of the assessment is a calculated dose.

    Sometimes more than one approach is used to estimateexposure.

    If more than one approach is used, the assessor shouldconsider how using each approach separately can verify orvalidate the others.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    56/93

    Establish the exposure assessment plan

    Before starting work on an exposure assessment, theassessor should have determined the purpose, scope,level of detail, and approach for the assessment, andshould be able to translate these into a set ofobjectives.

    These objectives will be the foundation for theexposure assessment plan

    The exposure assessment plan should reflect (inaddition to the objectives) an understanding of howthe results of the exposure assessment will be used inthe risk assessment.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    57/93

    Planning an exposure assessment as

    part of a risk assessment

    Exposure information must be clearly linked to thehazard identification and dose-response relationship

    Hazard identification and dose-response relationships

    can have a major effect on how the exposureinformation must be collected and analyzed for a riskassessment.

    Some of these aspects include implications of limitedversus repeated exposures, dose-rate considerations,reversibility of toxicological processes, andcomposition of the exposed population.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    58/93

    Limited versus repeated exposures

    Lifetime time-weighted average doses in the dose-response relationships owing to their derivation fromlifetime animal studies. This does not mean cancercannot occur after single exposures, merely thatexposure information must be consonant with the

    source of the model Some toxic effects, however, occur after a single or a

    limited number of exposures, including acutereactions such as anesthetic effects and respiratorydepression or certain developmental effects followingexposure during pregnancy

    For developmental effects, for example, lifetimetime-weighted averages have little relevance, in thiscase usually shorter-term exposure profile data during

    a particular time window

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    59/93

    Dose-rate effects. The use of average daily exposure values (e.g., ADD,

    LADD) in a dose-response relationship assumes that

    within some limits, increments of C times T

    (exposure concentration times time) that are equal in

    magnitude are equivalent in their potential to cause an

    effect, regardless of the pattern of exposure (the so-

    called Habers Rule; see Atherley, 1985).

    In those cases where toxicity depends on the dose

    rate, one may need a more precise determination ofthe time people are exposed to various concentrations

    and the sequence in which these exposures occur.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    60/93

    Composition of the exposed population

    The type of health effect may vary as a function of

    age or sex. Likewise, certain behaviors (e.g.,

    smoking), diseases (e.g., asthma), and genetic traits

    (e.g., glucose-6-phosphate dehydrogenase deficiency)may affect the response of a person to a chemical

    substance.

    Special population segments, such as children, may

    also call for a specialized approach to data collection

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    61/93

    Establishing the sampling strategy

    If the objectives of the assessment are to be met using

    measurements, it is important to establish the

    sampling strategy before samples are actually taken.

    The sampling strategy includes setting data qualityobjectives, developing the sampling plan and design,

    using spiked and blank samples, assessing

    background levels, developing quality assurance

    project plans, validating previously generated data,and selecting and validating analytical methods.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    62/93

    Data quality objectives

    All measurements are subject to uncertainty becauseof the inherent variability in the quantities beingmeasured (e.g., spatial and temporal variability) andanalytical measurement variability introduced during

    the measurement process through sampling andanalysis

    The larger the variability associated with individualmeasurements, the lower the data quality, and thegreater the probability of errors in interpretation.

    Data quality objectives (DQOs) describe the degreeof uncertainty that an exposure assessor and otherscientists and management are willing to accept

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    63/93

    Factors associated with data quality

    Realistic DQOs are essential. Data of insufficient quality willhave little value, while data of quality vastly in excess of whatis needed to answer the questions asked provide few, if any,additional advantages.

    DQOs should consider data needs, cost-effectiveness, and the

    capability of the measurement process. The amount of data required depends on the level of detail

    necessary for the purpose of the assessment

    Estimates of the number of samples to be taken andmeasurements to be made should account for expected sample

    variability.

    Finally, DQOs help clarify study objectives by compelling theexposure assessor to establish how the data will be used beforethey are collected

    D t it i

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    64/93

    Data criteria A clear statement of study objectives, to include an estimation

    of the key study parameters, identifying the hypotheses being

    tested, the specific aims of the study, and how the results willbe used.

    The scope of study objectives, to include the minimum size ofsub-samples from which separate results may be calculated,and the largest unit (area, time period, or group of people) the

    data will represent. A description of the data to be obtained, the media to be

    sampled, and the capabilities of the analytical methodologies.

    The acceptable probabilities and uncertainties associated withfalse positive and false negative statements.

    A discussion of statistics used to summarize the data; anystandards, reference values, or action levels used forcomparison; and a description and rationale for anymathematical or statistical procedures used.

    An estimate of the resources needed.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    65/93

    Sampling plan

    The sampling plan specifies how a sample is to be selected andhandled. An inadequate plan will often lead to biased,unreliable, or meaningless results. Good planning makesoptimal use of limited resources and is more likely to producevalid results.

    The sampling design specifies the number and types ofsamples needed to achieve DQOs. Factors to be considered indeveloping the sampling design include study objectives,sources of variability (e.g., temporal and spatial heterogeneity,analytical differences) and their relative magnitudes, relativecosts, and practical limitations of time, cost, and personnel.

    Sampling design considers the need for temporal and spatialreplication, compositing (combining several samples prior toanalysis), and multiple determinations on a single sample. Astatistical or environmental process model may be used toallocate sampling effort in the most efficient manner.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    66/93

    Stratified sampling plan if differences exist between segments of the statistical

    population being sampled

    It assures representative samples of the obviously differentparts of the sample population while reducing variance in thesample data.

    The survey approach estimates population exposure based on

    the measured exposure of a statistically representative sampleof the population.

    In some situations the study objectives are better served by anexperimental approach; this approach involves experimentsdesigned to determine the relationship between two or more

    factors (e.g., between house construction and a particularindoor air pollutant). In the experimental approach,experimental units are selected to cover a range of situations(e.g., different housing types), but do not reflect the frequencyof those units in the population of interest.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    67/93

    Stratified sampling plan (continued)

    An understanding of the relationship between factorsgained from an experiment can be combined withother data (e.g., distribution of housing types) toestimate exposure.

    An advantage of the experimental approach is that itmay provide more insight into underlyingmechanisms which may be important in targetingregulatory action.

    However, as in all experimental work, one must arguethat the relationships revealed apply beyond thatparticular experiment.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    68/93

    Factors associated with sampling locations

    Population density

    Historical sampling results

    Patterns of environmental contamination andenvironmental characteristics such as stream

    flow or prevailing wind direction, access to the

    sample site

    Types of samples, and health and safety

    requirements

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    69/93

    Sampling frequency and duration

    Depend on whether the risk assessor is

    concerned with acute or chronic exposures

    How rapidly contamination patterns are

    changing

    Ways in which chemicals are released into the

    environment

    Whether and to what degree physical

    conditions are expected to vary in the future.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    70/93

    Factors associated with sampling

    duration

    The analytical method chosen

    The limits of detection

    The physical and chemical properties of the analyte

    Chemical concentration Knowledge of transport and transformationmechanisms.

    Extension to ensure adequate collection of a chemicalat low concentration or curtailed to prevent the

    breakthrough of one at high concentration. Direct relation to selection of statistical procedures,

    such as trend or cross-sectional analyses.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    71/93

    Sample storage

    Storage stability

    Chemicals are prone to break down or have highvolatility, it is advisable to run a storage stabilitystudy in advance so that proper storage and maximum

    time of storage can be determined prior to samplecollection and storage

    samples should be analyzed as soon as possible aftercollection to avoid storage stability problems

    Individual programs may have specific time limits onstorage, depending on the types of samples beinganalyzed

    Quality assurance samples

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    72/93

    Quality assurance samples

    Sampling should be planned o ensure that thesamples are not biased by the introduction offield or laboratory contaminants

    Field- and laboratory-spiked samples and

    blank samples should be analyzed concurrentlyto validate results.

    The plan should provide instructions clearenough so that each worker can collect,

    prepare, preserve, and analyze samplesaccording to established protocols

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    73/93

    Guidance for quality assurance For volatiles and semi-volatiles, no positive sample results

    should be reported unless the concentration of the compoundin the sample exceeds 10 times the amount in any blank for thecommon laboratory contaminants methylene chloride, acetone,toluene, 2-butanone, and common phthalate esters.

    The amount for other volatiles and semi-volatiles shouldexceed 5 times the amount in the blank (U.S. EPA, 1988d).

    For pesticides and polychlorinated biphenyls (PCBs) nopositive sample results should be reported unless theconcentration in the sample exceeds 5 times that in the blank

    (U.S. EPA,1

    988d). If a pesticide or PCB is found in a blankbut not in a sample, no action is taken.

    For inorganics, no positive sample results should be reported ifthe results are less than 5 times the amount in any blank (U.S.EPA, 1988e).

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    74/93

    Background level

    Background presence may be due to natural oranthropogenic sources.

    At some sites, it is significant and must be accountedfor.

    The exposure assessor should try to determine localbackground concentrations by gathering data fromnearby locations clearly unaffected by the site underinvestigation.

    When differences between a background (controlarea) and a target site are to be determinedexperimentally, the control area must be sampledwith the same detail and care as the target.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    75/93

    Quality Assurance andQuality Control

    Quality assurance begins with the establishment ofDQOs and continues throughout the measurementprocess

    Each laboratory should have a QA program and, foreach study, a detailed quality assurance project plan,with language clear enough to preclude confusion andmisunderstanding

    The plan should list the DQOs and fully describe theanalytes, all materials, methods, and procedures used,and the responsibilities of project participants.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    76/93

    Quality control

    Quality control (QC) ensures a product or service issatisfactory, dependable, and economical.

    A QC program should include development and strict

    adherence to principles of good laboratory practice,consistent use of standard operational procedures, andcarefully-designed protocols for each measurementeffort.

    The program should ensure that errors have beenstatistically characterized and reduced to acceptablelevels.

    S l ti d lid ti f l ti l

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    77/93

    Selection and validation of analytical

    Methods

    First, the assessor establishes methods requirements.

    Next, existing methods are reviewed for suitability tothe current application.

    If a new method must be developed, it is subjected tofield and laboratory testing to determine itsperformance; these tests are then repeated by otherlaboratories using a round robin test.

    Finally, the method is revised as indicated by

    laboratory testing. The reader is referred to GuidanceforData Useability in Risk Assessment (U.S. EPA,1990b) for extensive discussion of this topic.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    78/93

    Establishing the modeling strategy

    The estimation of pollutant concentrations atexposure points is usually carried out by acombination of field data and mathematical modelingresults

    In the absence of field data, this process often relieson the results of mathematical models (U.S. EPA,1986e, 1987b, 1987c, 1988f, 1991b).

    EPAs Science Advisory Board (U.S. EPA, 1989b)has concluded that, ideally, modeling should belinked with monitoring data in regulatoryassessments, although this is not always possible

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    79/93

    Aspects of modeling strategy

    Setting objectives

    Model selection

    Obtaining and installing the code Calibrating and running the computer model

    Validation and verification

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    80/93

    Setting the modeling study objectives

    The first step in using a model to estimate

    concentrations and exposure is to clearly define the

    goal of the exposure assessment

    How the model can help address the questions orhypotheses of the assessment.

    This includes a clear statement of what information

    the model will help estimate, and how this estimate

    will be used. The approach must be consistent withknown project constraints

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    81/93

    Characterization and model selection

    Regardless of whether models are extensively used in

    an assessment and a formal modeling strategy is

    documented in the exposure assessment plan

    When computer simulation models such as fate andtransport models and exposure models are used in

    exposure assessments, the assessor must be aware of

    the performance characteristics of the model and state

    how the exposure assessment requirements aresatisfied by the model.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    82/93

    Characterization and model selection

    If models are to be used to simulate pollutantbehavior at a specific site, the site must becharacterized.

    Site characterization for any modeling study includes

    examining all data on the site such as sourcecharacterization, dimensions and topography of thesite, location of receptor populations, meteorology,soils, geohydrology, and ranges and distributions ofchemical concentrations.

    For exposure models that simulate both chemicalconcentration and time of exposure (through behaviorpatterns) data on these two parameters must beevaluated.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    83/93

    Characterization and model selection

    For all models, the modeler must determine ifdatabases are available to support the site,chemical, or population characterization, and

    that all parameters required by the model canbe obtained or reasonable default values areavailable.

    The assessment goals and the results of the

    characterization step provide the technicalbasis for model selection.

    S l ti f d l

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    84/93

    Selection of a model Criteria are provided in U.S. EPA (1987b, 1988f) for selection

    of surface water models and ground-water modelsrespectively; the reader is referred to these documents fordetails. Similar selection criteria exist for air dispersion models(U.S. EPA, 1986e, 1987c, 1991b).

    A screening study makes a preliminary evaluation of a site or ageneral comparison between several sites.

    Screening studies can help direct data collection at the site by,for example, providing an indication of the level of detectionand quantification and the distances and directions from a

    point of release where chemical concentrations might beexpected to be highest

    Screening-level models are frequently used to get a firstapproximation of the concentrations. Often these models usevery conservative assumptions and tend to overpredictconcentrations or exposures

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    85/93

    Selection of a model

    A detailed study is one in which the purpose is

    to make a detailed evaluation of a specific site.

    The approach is to use the best data available

    to make the best estimate of spatial and

    temporal distributions of chemicals.

    Detailed studies typically require much more

    data of higher quality and models of greatersophistication

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    86/93

    Implementation criteria of a model

    Criteria for using a model include its demonstrated

    acceptability and the ease with which the model can

    be obtained

    Factors include availability of specific models andtheir documentation, verification, and validation

    These so-called implementation criteria relate to the

    practical considerations of model use and may be

    used to further narrow the selection of technicallyacceptable models

    Calibrating the model

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    87/93

    Calibrating the model

    Calibration is the process of adjusting selected model

    parameters within an expected range until the differencesbetween model predictions and field observations are withinselected criteria

    Calibration is highly recommended for all operational,deterministic models

    Calibration accounts for spatial variations not represented bythe model formulation; functional dependencies of parametersthat are either non-quantifiable, unknown, or not included inthe model algorithms; or extrapolation of laboratorymeasurements to field conditions.

    Extrapolation of laboratory measurements to field conditionsrequires considerable care since many unknown factors maycause differences between laboratory and field

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    88/93

    Running the model

    Experience and familiarity with a model can also beimportant.

    Detailed models can be quite complex with a largenumber of input variables, outputs, and computer-related requirements.

    It frequently takes months to years of experience tofully comprehend all aspects of a model.

    Consequently, an exposure assessor select a familiarmodel if it possesses all the selection criteria, or seekthe help of experienced exposure modelers.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    89/93

    Model validation

    Model validation is a process by which the accuracyof model results is compared with actual data fromthe system being simulated

    In essence, validation is an independent test of howwell the model (with its calibrated parameters)represents the important processes occurring in thenatural system

    Although field and environmental conditions areoften different during the validation step, parametersfixed as a result of calibration are not readjustedduring validation

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    90/93

    Performance of models

    Dramatically influenced by site characterization andhow models represent such characteristics.

    Characterizing complex, heterogenous physicalsystems presents major challenges; modeling

    representations of such systems must be evaluated inlight of that difficulty.

    In many cases, the apparent inability to model asystem is caused by incomplete physicalcharacterization of the system.

    In other cases the uncertainties cannot be readilyapportioned between the model per se and themodels input data.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    91/93

    Limitations of models

    The model validation process provides information

    about conditions under which a simulation will be

    acceptable and accurate, and under what conditions it

    should not be used at all All models have specific ranges of application and

    specific classes of chemicals for which they are

    appropriate. Assessors should be aware of these

    limitations as they develop modeling strategies

    Planning an exposure assessment to

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    92/93

    Planning an exposure assessment to

    assess past exposures

    If the data are being collected to assess past

    exposures, such as in epidemiologic studies,

    they need to be representative of the past

    exposure conditions, which may have changedwith time.

    The scope and level of detail of the assessment

    depends greatly on the availability and qualityof past data.

  • 8/8/2019 Health Risk Assessment (VI)New1201 2010

    93/93

    Homework

    Soil and underground water of a site was

    identified contaminated with benzene. Health

    risk will be conducted to determine the

    cleanup goal for this site. Please design anexposure assessment plan for setting the

    cleanup goal based on risk assessment.